Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
cancer
4
×
fda
4
×
life sciences
national blog main
boston top stories
clinical trials
europe blog main
ipo
new york blog main
new york top stories
san francisco blog main
biogen
boulder/denver blog main
boulder/denver top stories
cancer drugs
deerfield management
detroit blog main
detroit top stories
drug discovery
europe top stories
gilead sciences
indiana blog main
indiana top stories
melinta therapeutics
national
national top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco top stories
sanofi
seattle blog main
seattle top stories
startups
takeda pharmaceutical
texas blog main
What
ipo
4
×
medicines
4
×
bio
covid
new
roundup
acquisitions
activity
announced
approvals
biogen
biotech
black
cancer
ceo
clamped
clinic
collabs
companies
company’s
course
daniel
deal
delays
developing
development
diamond
discover
drug
economic
eluded
experimental
fast
fda
gilead
gilead’s
growing
handiwork
help
helped
Language
unset
Current search:
medicines
×
cancer
×
fda
×
ipo
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Schrödinger Sets Course for IPO to Support Growing Internal Pipeline
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic